We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTZ icon
26
Hertz
HTZ
$632M
$540K 0.27%
+104,972
New +$573K
PL icon
27
Planet Labs
PL
$7.48B
$533K 0.27%
27,048
-1,320
-5% -$18.9K
LITE icon
28
Lumentum
LITE
$55.4B
$533K 0.27%
+1,445
New +$371K
CAAP icon
29
Corporacion America
CAAP
$4.28B
$532K 0.27%
20,455
-15,731
-43% -$352K
SYM icon
30
Symbotic
SYM
$5.28B
$530K 0.27%
+8,911
New +$588K
COLD icon
31
Americold
COLD
$4.17B
$524K 0.27%
+40,714
New +$499K
TLS icon
32
Telos
TLS
$346M
$523K 0.26%
+102,564
New +$640K
PLAB icon
33
Photronics
PLAB
$1.76B
$521K 0.26%
+16,280
New +$420K
BRZE icon
34
Braze
BRZE
$2.65B
$519K 0.26%
15,150
+6,286
+71% +$186K
SPHR icon
35
Sphere Entertainment
SPHR
$5.01B
$517K 0.26%
+5,438
New +$414K
EXTR icon
36
Extreme Networks
EXTR
$3.92B
$516K 0.26%
31,012
+16,567
+115% +$304K
PGY icon
37
Pagaya Technologies
PGY
$1.41B
$514K 0.26%
+24,617
New +$627K
WK icon
38
Workiva
WK
$3.13B
$508K 0.26%
+5,892
New +$522K
WPM icon
39
Wheaton Precious Metals
WPM
$50.9B
$507K 0.26%
+4,318
New +$462K
HOLX
40
DELISTED
Hologic
HOLX
$507K 0.26%
6,803
+3,539
+108% +$259K
NRIM icon
41
Northrim BanCorp
NRIM
$595M
$503K 0.25%
+18,884
New +$448K
LYFT icon
42
Lyft
LYFT
$5.73B
$502K 0.25%
+25,934
New +$539K
GCMG icon
43
GCM Grosvenor
GCMG
$756M
$501K 0.25%
44,256
+8,071
+22% +$92.2K
CAH icon
44
Cardinal Health
CAH
$53.7B
$486K 0.25%
2,367
+868
+58% +$163K
NBR icon
45
Nabors Industries
NBR
$1.16B
$486K 0.25%
+8,948
New +$436K
DCH
46
Dauch Corp
DCH
$1.32B
$486K 0.25%
75,794
+23,727
+46% +$148K
VRSN icon
47
VeriSign
VRSN
$24.8B
$485K 0.25%
1,998
+1,234
+162% +$310K
PRG icon
48
PROG Holdings
PRG
$1.73B
$483K 0.24%
+16,380
New +$488K
SYK icon
49
Stryker
SYK
$129B
$481K 0.24%
+1,369
New +$499K
MLCO icon
50
Melco Resorts & Entertainment
MLCO
$2.18B
$474K 0.24%
62,676
+18,381
+41% +$154K
1
2
3 4 5

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.